January 09, 2007
Adult stem cells spur market rush, avoid embryo ban
Bloomberg News, January 9, 2007
Five-month-old Luis Fernando Rojo was near death in a Miami hospital, suffering with blisters and bloody diarrhea after his tiny body rejected part of a marrow transplant for a rare bone disorder. So U.S. regulators allowed Luis's doctors to try an unapproved therapy from Baltimore-based Osiris Therapeutics Inc. Osiris, which first sold shares to the public on August 4, was founded in 1992 using technology developed by Arnold Caplan, a stem cell researcher at Case Western Reserve University in Cleveland. Read article.
Posted by: Heidi Cool, January 9, 2007 11:04 AM | News Topics: Bloomberg News, College of Arts and Sciences, Faculty, Health, Research
http://blog.case.edu/caseinthenews/2007/01/09/adult_stem_cells_spur_market_rush_avoid_embryo_ban
Office of Marketing and Communications
http://www.case.edu/univrel/marcomm/
216.368.4440
